TRIESENCE Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Triesence patents expire, and when can generic versions of Triesence launch?
Triesence is a drug marketed by Novartis and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-five patent family members in twenty-one countries.
The generic ingredient in TRIESENCE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Triesence
A generic version of TRIESENCE was approved as triamcinolone acetonide by TARO on October 1st, 1986.
Summary for TRIESENCE
International Patents: | 25 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 75 |
Clinical Trials: | 10 |
Patent Applications: | 2,768 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIESENCE |
What excipients (inactive ingredients) are in TRIESENCE? | TRIESENCE excipients list |
DailyMed Link: | TRIESENCE at DailyMed |


Recent Clinical Trials for TRIESENCE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Oxular Limited | Phase 2 |
Wake Forest University Health Sciences | Phase 4 |
Duke University | N/A |
Anatomical Therapeutic Chemical (ATC) Classes for TRIESENCE
US Patents and Regulatory Information for TRIESENCE
TRIESENCE is protected by three US patents.
Patents protecting TRIESENCE
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: VISUALIZATION DURING VITRECTOMY PROCEDURES
Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: TREATMENT OF OPHTHALMIC DISORDERS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
Novartis | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRIESENCE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | TRIESENCE | triamcinolone acetonide | INJECTABLE;INTRAVITREAL | 022048-001 | Nov 29, 2007 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for TRIESENCE
See the table below for patents covering TRIESENCE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 2010009974 | SUSPENSIONES DE ACETONIDA DE TRIAMCINOLONA DE BAJA VISCOSIDAD, ALTAMENTE FLOCULADAS PARA INYECCION INTRAVITREA. (LOW VISCOSITY, HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTION.) | See Plans and Pricing |
Japan | 2011513492 | See Plans and Pricing | |
Argentina | 070824 | SUSPENSIONES PARA INYECCION INTRAVITREA DE TRIAMCINOLONA ACETONIDO DE BAJA VISCOSIDAD, ALTAMENTE FLOCULADAS | See Plans and Pricing |
Taiwan | 200940071 | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection | See Plans and Pricing |
European Patent Office | 2262506 | SUSPENSIONS D ACÉTONIDE DE TRIAMCINOLONE TRÈS FLOCULÉES ET DE FAIBLE VISCOSITÉ POUR INJECTION INTRAVITRÉENNE (LOW VISCOSITY, HIGHLY FLOCCULATED TRIAMCINOLONE ACETONIDE SUSPENSIONS FOR INTRAVITREAL INJECTION) | See Plans and Pricing |
Uruguay | 31699 | SUSPENSIONES DE ACETONIDO DE TRIAMCINOLONA DE BAJA VISCOSIDAD Y ELEVADA FLOCULACION PARA INYECCION INTRAVITREA | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2009114521 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |